LUNGevity Blog
67 FOLLOWERS
LUNGevity is changing outcomes for people with lung cancer through research, education, and support. We seek to empower patients to be active decision-makers in their treatment process through our extensive educational resources, online peer-to-peer support, and in-person survivorship programs.
LUNGevity Blog
11M ago
It’s been more than 3 years since the US Department of Health and Human Services (HHS) first declared a nationwide Public Health Emergency (PHE) due to COVID-19. Since then, periodic renewals of the PHE have increased the flexibility of healthcare delivery. The PHE is set to end on May 11, 2023. A separate National Emergency that was enacted due to COVID-19 ended on April 10. Of the two, the end of the PHE will be more consequential for day-to-day healthcare delivery.   ..read more
LUNGevity Blog
1y ago
The first week of April definitely started with a bang! After the 2019 in-person small cell lung cancer (SCLC) meeting—convened by the International Association for the Study of Lung Cancer (IASLC) and hosted by Memorial Sloan Kettering Cancer in New York—the pandemic hit us in 2020 ..read more
LUNGevity Blog
1y ago
So how did I get lung cancer? Well, if you’re a lung cancer patient like me, I’m certain that this all too common question has played over and over in your mind as well; much like an endless repeat of a badly broken record (and yes, in light of today’s technology I am unabashedly dating myself here ..read more
LUNGevity Blog
1y ago
Participating in a clinical trial gives patients the ability to try the newest treatments that otherwise are not available. There are many ongoing clinical trials testing new lung cancer treatments, including targeted therapies, chemotherapy, radiation therapy, and immunotherapy, alone and in combination.   ..read more
LUNGevity Blog
1y ago
Each year, there is one key conference dedicated to bringing stakeholders together with the sole goal of discussing the development of treatments for thoracic cancer — the Targeted Therapies of Lung Cancer Meeting ..read more
LUNGevity Blog
1y ago
By Cecili Weber, Development & Foundation Content Manager, February 14, 2023 ..read more
LUNGevity Blog
1y ago
By Nick Baker, Website Content Manager, February 3, 2023 presents the #CloseTheCareGap initiative. February 4, 2023 will be a day focused on promoting equity in the cancer space ..read more
LUNGevity Blog
1y ago
Tumors that have the ALK protein fused with another cancer-driving protein, such as the EML4 protein, are often referred to as ALK-positive tumors. Approximately 5% of advanced-stage adenocarcinoma, a type of NSCLC, will test positive for an ALK-fusion biomarker. Treating patients with ALK-positive lung cancer with a class of drugs called tyrosine kinase inhibitors (TKIs) has been an effective approach. However, as seen in other types of lung cancers treated with TKIs, eventually the tumors develop resistance to treatment and the tumor begins to grow again.   ..read more
LUNGevity Blog
1y ago
Her doctor was excited, which made Nina excited. They high-fived and couldn’t believe the progress that had been made in just a few weeks. The clinical trial was already having positive effects. Before her clinical trial success, Nina went through the standard treatments for people with small-cell lung cancer (SCLC). She was diagnosed in early 2014, and the plan was to try different chemo and radiation therapies.  ..read more
LUNGevity Blog
1y ago
Overall health becomes a major priority when undergoing lung cancer treatment, and staying active is one way to include healthy behaviors in your life. Talking with your doctor about exercise and lung cancer is important to remain safe and do activities your body and lungs can handle. If you feel chest or lung pain during any workouts, stop immediately and tell your doctor.  ..read more